Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc.BSTG · Entity 7501 | Director · President and CMO | August 24, 2017 | August 25, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Harvard Apparatus Regenerative Technology, Inc.
Report date August 24, 2017 · Filed August 25, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 293,998 |
Reported balance
After 2017-08-24 transaction · row 1
1 source rowRow 1 · 2017-08-24 · Purchase · Acquired 100,000 · Balance 293,998 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2017 Filed Aug 25, 2017 08:00 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 100,000 | $0.37 | $37,000.00 |
DisclosureSEC source: 0001144204-17-045073 · v474033_4.xml · nonDerivative · entry 1 LaFrancesca Saverio · CIK 0001641900 · Director · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,998 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 08:01 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 150,000 | $0.32 | $48,000.00 |
DisclosureSEC source: 0001144204-17-044867 · v473946_form4.xml · nonDerivative · entry 1 LaFrancesca Saverio · CIK 0001641900 · Director · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,998 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.29 to $0.34, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 16:17 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantRestricted Stock Units · Derivative | 107,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-015097 · v461956_4.xml · derivative · entry 2 LaFrancesca Saverio · CIK 0001641900 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,250 Underlying: Common Stock, par value $0.01 per share · 107,250 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units granted by the Issuer pursuant to its 2013 Equity Incentive Plan and qualified under Rule 16b-3(d). Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. F3 · derivative.exercise_date: The restricted stock units vest and settle in four equal installments on March 14, 2018, 2019, 2020 and 2021. F3 · derivative.expiration_date: The restricted stock units vest and settle in four equal installments on March 14, 2018, 2019, 2020 and 2021. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 16:17 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 217,750 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001144204-17-015097 · v461956_4.xml · derivative · entry 1 LaFrancesca Saverio · CIK 0001641900 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,750 Underlying: Common Stock, par value $0.01 per share · 217,750 shares Expires 2027-03-14 F1 · derivative.exercise_date: The option shares vest in four equal installments on March 14, 2018, 2019, 2020 and 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.